Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > The RBC report for April-21-2016
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by argentia77on May 10, 2016 6:04am
129 Views
Post# 24856730

RE:RE:RE:RE:RE:The RBC report for April-21-2016

RE:RE:RE:RE:RE:The RBC report for April-21-2016
Lattice wrote: That's nice Scruggs, but we were talking about Donnatal.  You know, the 90 year old archaic drug. 


Lattice, I'm disapointed in you. Donnatel is in good company. Aspirin is 150 years old and penicillin at least 90 years old. So if you don't want to get fukt by everyone who sees your silly posts just keep your legs together!  

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities